Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

UBE2I anticorps (AA 33-158)

UBE2I Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1872071
  • Antigène Voir toutes UBE2I Anticorps
    UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
    Épitope
    • 7
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 33-158
    Reactivité
    • 72
    • 35
    • 34
    • 7
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 58
    • 13
    • 2
    Lapin
    Clonalité
    • 48
    • 25
    Polyclonal
    Conjugué
    • 38
    • 6
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    Cet anticorp UBE2I est non-conjugé
    Application
    • 49
    • 26
    • 23
    • 10
    • 8
    • 8
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Fonction
    Polyclonal Antibody to Ubiquitin Conjugating Enzyme E2I (UBE2I)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against UBE2I. It has been selected for its ability to recognize UBE2I in immunohistochemical staining and western blotting.
     Réactivité croisée
    Souris, Porc, Rat
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Ubiquitin Conjugating Enzyme E2I (UBE2I) corresdonding to Asp33~Ser158 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product UBE2I Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL

    Immunohistochemistry: 5-20 μg/mL

    Immunocytochemistry: 5-20 μg/mL

    Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
    Autre désignation
    Ubiquitin Conjugating Enzyme E2I (UBE2I Produits)
    Synonymes
    anticorps C358B7.1, anticorps P18, anticorps UBC9, anticorps ubc9, anticorps ube2ia, anticorps zUbc9, anticorps 5830467E05Rik, anticorps F830028O17Rik, anticorps Ubce2i, anticorps Ubce9, anticorps UbcE2A, anticorps ubce9, anticorps T13J8.70, anticorps T13J8_70, anticorps UBIQUITIN-PROTEIN LIGASE, anticorps ubiquitin conjugating enzyme 9, anticorps ubiquitin conjugating enzyme E2 I, anticorps ubiquitin-conjugating enzyme E2Ib, anticorps ubiquitin-conjugating enzyme E2L, anticorps ubiquitin-conjugating enzyme E2I, anticorps ubiquitin conjugating enzyme E2I S homeolog, anticorps ubiquitin conjugating enzyme 9, anticorps SUMO-conjugating enzyme UBC9, anticorps UBE2I, anticorps ube2ib, anticorps UBE2L, anticorps Ube2i, anticorps ube2i.S, anticorps UBC9, anticorps ubc-9, anticorps LOC108703134
    Sujet
    P18, UBC9, UBCE9, SUMO-protein ligase, Ubiquitin carrier protein 9, Ubiquitin carrier protein I, Ubiquitin-protein ligase I, SUMO-conjugating enzyme UBC9
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Ubiquitin Proteasome Pathway
Vous êtes ici:
Support technique